Delivery Order SPE2DB22D3004-SPE2DB25FRF73

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,278.76 Firm Fixed Price Delivery Order contract is for the supply of the medication EMVERM 100 MG TABLET CHEW UDS. The award has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award, valued at $4,747.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product, with a period of performance through May 1, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,383.49, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,462.31, is a Firm Fixed Price Delivery Order for the supply of EMVERM 100 MG TABLET CHEW, a medication. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,707.62 firm fixed-price delivery order is for the provision of 4567421566 ! EMVERM 100 MG TABLET CHEW UDS medical supplies. The contract has a period of performance through March 3, 2025 and was awarded on February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0ZY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,213.77 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. It is not a set-aside contract, indicating open...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of EMVERM 100 MG TABLET CHEW medical supplies. The contract, valued at $24,685.31, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of March 19, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,065.53, is for the delivery of EMVERM 100 MG TABLET CHEW UDS medical products. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 7, 2025. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,774.92, is a delivery order for the supply of EMVERM 100 MG TABLET CHEW UDS medical products. It is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp is a Firm Fixed Price Delivery Order worth $2,183.96 to provide 4557842219 - EMVERM 100 MG TABLET CHEW UDS to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 20, 2022 and was awarded on July 19, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FRF73
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,450.35 firm fixed-price delivery order is for the supply of the medication EMVERM 100 MG TABLET CHEW UDS, with a completion date of June 30, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award described is not designated as a set-aside.

Generated 9/26/25, 9:45 AM